Endo Pharmaceuticals Holdings Inc (ENDP) 84.01 $ENDP
11.9% Return Seen to Date on SmarTrend Endo Pharmaceuticals Call (ENDP)
Comtex SmarTrend(R) - Fri Feb 13, 10:03AM CST
SmarTrend identified an Uptrend for Endo Pharmaceuticals (NASDAQ:ENDP) on December 29th, 2014 at $73.97. In approximately 2 months, Endo Pharmaceuticals has returned 11.93% as of today's recent price of $82.80.
ENDP: 84.01 (+1.12)
Endo to Announce Fourth Quarter 2014 Financial Results on March 2, 2015
PR Newswire Europe - Fri Feb 13, 8:00AM CST
Endo International plc will announce its fourth quarter 2014 financial results before the open of the U.S. financial markets on March 2, 2015 and members of its senior management team will host a conference call and webcast at 8:30 a.m. ET that day.
ENDP: 84.01 (+1.12), ENL.TO: 103.00 (unch)
Alaska AG investigating Impax Labs over possible pay-to-delay deals
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 4:33PM CST
IPXL: 39.51 (+0.69), ENDP: 84.01 (+1.12), PFE: 34.64 (-0.23), SHPG: 239.82 (+6.11)
6 Big Pharmaceutical Companies You Don't Want In Your Portfolio
at The Street - Tue Feb 10, 7:17AM CST
Which big pharmaceutical stocks should investors stay away from in 2015?
MNK: 115.01 (+2.51), ENDP: 84.01 (+1.12), JAZZ: 169.69 (+6.89), AZN: 69.96 (+0.20), SLXP: 152.35 (+3.17), GSK: 47.94 (+1.99)
Paladin Labs Announces the Canadian Launch of Zincofax® Spray
CNW Group - Mon Feb 09, 4:02PM CST
Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), announced today the launch of Zincofax® Spray, a new, spray-on ointment from the makers of Zincofax®, the trusted and established brand for diaper rash ointments.
ENDP: 84.01 (+1.12), ENL.TO: 103.00 (unch)
Can Endo International (ENDP) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 7:52AM CST
Endo International a firm in the Medical-Drugs space could be in a great position to keep earnings streak alive this season
ENDP: 84.01 (+1.12)
BioSpecifics Announces Label Expansion for Xiaflex in EU - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 2:31PM CST
Positive news flowed in for BioSpecifics Technologies Corp. (BSTC) when Swedish Orphan Biovitrum AB received approval from the European Commission to market Xiapex for an additional indication.
ENDP: 84.01 (+1.12), BSTC: 38.14 (-0.85), SCMP: 15.32 (+0.04), BIOD: 1.38 (-0.14)
Looking For Opportunity In Endo's Structural Changes
Max Grigoryev - at Seeking Alpha - Thu Feb 05, 1:56PM CST
ENDP: 84.01 (+1.12)
Endo Pharmaceuticals Falls 2.30% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Feb 04, 4:10PM CST
Endo Pharmaceuticals (NASDAQ:ENDP) traded in a range yesterday that spanned from a low of $77.23 to a high of $79.32. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $78.21 on volume of 3.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ENDP: 84.01 (+1.12)
American Medical Systems (AMS) sponsors Healthy Body Healthy Mind episode to raise awareness of Stress Urinary Incontinence and treatment options
PR Newswire Europe - Tue Feb 03, 7:31AM CST
American Medical Systems Inc. (AMS), a subsidiary of Endo International plc and leading provider of medical technologies for pelvic health, is proud to be a sponsor of an episode of the popular Healthy Body Healthy Mind series titled "Managing Female Stress Urinary Incontinence." The episode began airing nationally on The National Public Television Network (PBS) in December.
ENDP: 84.01 (+1.12), ENL.TO: 103.00 (unch)
Paladin Labs Announces the Canadian Launch of Dynamiclear Rapid(TM)
CNW Group - Mon Feb 02, 3:30PM CST
Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), announced today the launch of Dynamiclear RapidTM, a new over-the-counter (OTC) topical single application cold sore product.(1)
ENDP: 84.01 (+1.12), ENL.TO: 103.00 (unch)
5 Rocket Stocks to Buy for February Gains: Apple, Mallinckrodt and More
at The Street - Mon Feb 02, 10:52AM CST
These stocks have both short-term gain catalysts and longer-term growth potential.
MNK: 115.01 (+2.51), ENDP: 84.01 (+1.12), TEL: 70.76 (+0.38), WEC: 50.96 (-1.31), AAPL: 127.08 (+0.62)
Endo completes acquisition of Auxilium
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 4:10PM CST
ENDP: 84.01 (+1.12)
Endo Completes Acquisition Of Auxilium Pharmaceuticals
PR Newswire Europe - Thu Jan 29, 3:30PM CST
Endo International plc today announced it has completed the acquisition of Auxilium Pharmaceuticals, Inc. in a transaction valued at $2.6 billion when announced on October 9, 2014. The closing of the transaction follows the approval of the acquisition by Auxilium's shareholders on January 27, 2015, and the receipt of all required regulatory approvals.
ENDP: 84.01 (+1.12), ENL.TO: 103.00 (unch), AUXL: 36.47 (-0.06)
11.9% Return Seen to Date on SmarTrend Endo Pharmaceuticals Call (ENDP)
Comtex SmarTrend(R) - Fri Feb 13, 10:03AM CST
SmarTrend identified an Uptrend for Endo Pharmaceuticals (NASDAQ:ENDP) on December 29th, 2014 at $73.97. In approximately 2 months, Endo Pharmaceuticals has returned 11.93% as of today's recent price of $82.80.
ENDP: 84.01 (+1.12)
Endo to Announce Fourth Quarter 2014 Financial Results on March 2, 2015
PR Newswire Europe - Fri Feb 13, 8:00AM CST
Endo International plc will announce its fourth quarter 2014 financial results before the open of the U.S. financial markets on March 2, 2015 and members of its senior management team will host a conference call and webcast at 8:30 a.m. ET that day.
ENDP: 84.01 (+1.12), ENL.TO: 103.00 (unch)
Alaska AG investigating Impax Labs over possible pay-to-delay deals
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 4:33PM CST
IPXL: 39.51 (+0.69), ENDP: 84.01 (+1.12), PFE: 34.64 (-0.23), SHPG: 239.82 (+6.11)
6 Big Pharmaceutical Companies You Don't Want In Your Portfolio
at The Street - Tue Feb 10, 7:17AM CST
Which big pharmaceutical stocks should investors stay away from in 2015?
MNK: 115.01 (+2.51), ENDP: 84.01 (+1.12), JAZZ: 169.69 (+6.89), AZN: 69.96 (+0.20), SLXP: 152.35 (+3.17), GSK: 47.94 (+1.99)
Paladin Labs Announces the Canadian Launch of Zincofax® Spray
CNW Group - Mon Feb 09, 4:02PM CST
Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), announced today the launch of Zincofax® Spray, a new, spray-on ointment from the makers of Zincofax®, the trusted and established brand for diaper rash ointments.
ENDP: 84.01 (+1.12), ENL.TO: 103.00 (unch)
Can Endo International (ENDP) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 7:52AM CST
Endo International a firm in the Medical-Drugs space could be in a great position to keep earnings streak alive this season
ENDP: 84.01 (+1.12)
BioSpecifics Announces Label Expansion for Xiaflex in EU - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 2:31PM CST
Positive news flowed in for BioSpecifics Technologies Corp. (BSTC) when Swedish Orphan Biovitrum AB received approval from the European Commission to market Xiapex for an additional indication.
ENDP: 84.01 (+1.12), BSTC: 38.14 (-0.85), SCMP: 15.32 (+0.04), BIOD: 1.38 (-0.14)
Looking For Opportunity In Endo's Structural Changes
Max Grigoryev - at Seeking Alpha - Thu Feb 05, 1:56PM CST
ENDP: 84.01 (+1.12)
Endo Pharmaceuticals Falls 2.30% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Feb 04, 4:10PM CST
Endo Pharmaceuticals (NASDAQ:ENDP) traded in a range yesterday that spanned from a low of $77.23 to a high of $79.32. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $78.21 on volume of 3.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ENDP: 84.01 (+1.12)
American Medical Systems (AMS) sponsors Healthy Body Healthy Mind episode to raise awareness of Stress Urinary Incontinence and treatment options
PR Newswire Europe - Tue Feb 03, 7:31AM CST
American Medical Systems Inc. (AMS), a subsidiary of Endo International plc and leading provider of medical technologies for pelvic health, is proud to be a sponsor of an episode of the popular Healthy Body Healthy Mind series titled "Managing Female Stress Urinary Incontinence." The episode began airing nationally on The National Public Television Network (PBS) in December.
ENDP: 84.01 (+1.12), ENL.TO: 103.00 (unch)
Paladin Labs Announces the Canadian Launch of Dynamiclear Rapid(TM)
CNW Group - Mon Feb 02, 3:30PM CST
Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), announced today the launch of Dynamiclear RapidTM, a new over-the-counter (OTC) topical single application cold sore product.(1)
ENDP: 84.01 (+1.12), ENL.TO: 103.00 (unch)
5 Rocket Stocks to Buy for February Gains: Apple, Mallinckrodt and More
at The Street - Mon Feb 02, 10:52AM CST
These stocks have both short-term gain catalysts and longer-term growth potential.
MNK: 115.01 (+2.51), ENDP: 84.01 (+1.12), TEL: 70.76 (+0.38), WEC: 50.96 (-1.31), AAPL: 127.08 (+0.62)
Endo completes acquisition of Auxilium
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 4:10PM CST
ENDP: 84.01 (+1.12)
Endo Completes Acquisition Of Auxilium Pharmaceuticals
PR Newswire Europe - Thu Jan 29, 3:30PM CST
Endo International plc today announced it has completed the acquisition of Auxilium Pharmaceuticals, Inc. in a transaction valued at $2.6 billion when announced on October 9, 2014. The closing of the transaction follows the approval of the acquisition by Auxilium's shareholders on January 27, 2015, and the receipt of all required regulatory approvals.
ENDP: 84.01 (+1.12), ENL.TO: 103.00 (unch), AUXL: 36.47 (-0.06)
